Medical Research News

RSS

Not all narcissism is alike. A study of 1,524 students reveals why that matters

Two studies involving 1,524 German university students found that narcissistic rivalry was associated with poorer psychological well-being, greater self-doubt, and lower academic satisfaction, while narcissistic admiration was associated with higher life satisfaction and better mood. Admiration also showed selective positive associations with academic satisfaction, particularly study content, although the cross-sectional findings cannot establish cause and effect.

10 Nov 2026

Scientists scanned people's brains before and after 45 days of yoga. Here's what changed

In a randomized controlled trial involving 139 healthy adults, 45 days of a standardized yoga program improved mood, self-reported sleep quality, and selected short-term memory measures compared with a waitlist control group. Brain scans from 43 participants also revealed changes in functional connectivity across networks involved in movement, attention, language, and cognitive processing, although the long-term significance remains uncertain

10 Nov 2026

Eating too much ultra-processed food? A study links it to worse PMS symptoms

A cross-sectional study of 607 young adult women in Turkey found that higher ultra-processed food consumption scores were associated with more severe premenstrual syndrome (PMS) symptoms, while non-judgmental and non-reactive mindful eating behaviors were linked to lower symptom severity. Mediterranean diet adherence was not independently associated with PMS severity, and the researchers cautioned that the findings cannot establish cause and effect.

10 Nov 2026

Could eating more mushrooms help protect your brain as you age?

A review of existing research suggests that ergothioneine, a natural antioxidant found primarily in mushrooms, may protect brain cells against oxidative stress, inflammation, and damage associated with Alzheimer's and Parkinson's diseases. Although laboratory and animal studies show promising neuroprotective effects, human evidence remains limited, and larger clinical trials are needed to determine whether supplementation can prevent or slow neurodegeneration.

10 Nov 2026

Artery scans detect “silent atherosclerosis” in 1 in 13 adults under 30

Researchers studying 16,808 adults aged 18 to 70 found that silent atherosclerosis was detectable in early adulthood, with plaque present in 57.1% of those who completed imaging across three arterial territories. Plaque prevalence and burden were higher in older age groups, with men showing earlier evidence of disease than women, while conventional cardiovascular risk scores identified relatively few people with existing plaque.

10 Nov 2026

Video-assisted informed consent shortens face-to-face cancer surgery consultations

For patients undergoing gastric cancer surgery, informed consent (IC) can involve extensive information about surgical methods, complications, risks, benefits, and life after treatment.

10 Nov 2026

Targeting brain cleaning gene could help treat or prevent Alzheimer's

A gene responsible for compacting trash inside the brain appears to be a key player in Alzheimer's disease, and doctors may be able to target it to better treat or help prevent the devastating condition, new UVA Health research suggests.

10 Nov 2026

Mayo Clinic research advances treatment options for genitourinary cancers

Cancers of the reproductive and urinary organs, known as genitourinary cancers, affect millions of people worldwide each year. Yousef Zakharia, M.D., a Mayo Clinic medical oncologist, leads clinical research aimed at improving treatment results for patients with kidney, bladder and prostate cancers.

10 Nov 2026

Protein marker detects early Huntington's disease before brain damage

Before motor or cognitive impairments appear and before brain volume loss becomes evident, some individuals carrying the genetic mutation that causes Huntington's disease already show signs of neuronal injury.

10 Nov 2026

Subtle changes in deep sleep before Alzheimer's symptoms appear

The study identifies slow-wave sleep alterations as potential biomarkers for Alzheimer's, emphasizing their role in cognitive health and disease progression.

10 Nov 2026

Regular coffee consumption alters gut bacteria and digestive physiology

If you drink coffee regularly, it appears to alter not only your gut bacteria but also the physiology of the gut itself. That is the conclusion of a study from the University of Copenhagen, which may help point the way towards better treatments for constipation.

10 Nov 2026

Common blood pressure drugs may improve ulcerative colitis therapy

A class of blood pressure medications may improve a widely used treatment for ulcerative colitis, the most common type of inflammatory bowel disease, suggests a new study, led by Northwestern Medicine and Kiel University in Germany, of thousands of patients with the disease.

10 Nov 2026

Meeting WHO's air pollution guidelines could save nine million lives

Meeting the World Health Organization's recommended annual guidelines for air pollution resulting from fine particulate matter and nitrogen dioxide has the potential to save more than 9 million lives a year in low- and middle-income countries, say University of Cambridge researchers.

10 Nov 2026

Tobacco use independently linked to anorectal sensorimotor dysfunction and fecal incontinence

Tobacco use is independently associated with anorectal sensorimotor dysfunction and fecal incontinence, according to a recent study published ahead of print in The American Journal of Gastroenterology.

10 Nov 2026

A weight-loss drug eased knee arthritis pain in two major trials

Retatrutide effectively alleviates knee pain and enhances mobility in obese osteoarthritis patients, but long-term safety and joint health remain uncertain.

10 Nov 2026

Could a common diabetes drug help prevent long COVID?

Metformin use soon after COVID-19 infection is associated with a 53% reduction in long COVID or death risk, reinforcing previous clinical findings.

10 Nov 2026

Could Ozempic and Wegovy affect unborn babies?

They’re the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted pounds.

10 Nov 2026

Lab Thread launches new AI tools and strengthens platform with universal AI assistant compatibility

Lab Thread Ltd, a UK-based life science software company, today announced the launch of a new Model Context Protocol (MCP) server that lets scientists connect their own AI assistants directly to their laboratory data.

From Lab Thread 10 Nov 2026

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight’s Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum’s lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

10 Nov 2026

European commission approves label expansion of Pepaxti to third-line treatment

Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, today announced that the European Commission (EC) has formally approved the Type II variation application for Pepaxti (melflufen).

From Oncopeptides AB (publ) 10 Nov 2026